Your browser doesn't support javascript.
loading
Deep brain stimulation of the subthalamic nucleus and the temporal discounting of primary and secondary rewards.
Aiello, M; Terenzi, D; Furlanis, G; Catalan, M; Manganotti, P; Eleopra, R; Belgrado, E; Rumiati, R I.
Afiliação
  • Aiello M; Area of Neuroscience, SISSA, via Bonomea 265, 34136, Trieste, Italy. maiello@sissa.it.
  • Terenzi D; Area of Neuroscience, SISSA, via Bonomea 265, 34136, Trieste, Italy.
  • Furlanis G; Azienda Ospedaliero-Universitaria "Ospedali Riuniti" of Trieste, Strada di Fiume 447, 34149, Trieste, Italy.
  • Catalan M; Azienda Ospedaliero-Universitaria "Ospedali Riuniti" of Trieste, Strada di Fiume 447, 34149, Trieste, Italy.
  • Manganotti P; Azienda Ospedaliero-Universitaria "Ospedali Riuniti" of Trieste, Strada di Fiume 447, 34149, Trieste, Italy.
  • Eleopra R; Fondazione IRCCS Istituto Neurologico Carlo Besta, UOC Neurologia 1, Via Celoria 11, 20133, Milan, Italy.
  • Belgrado E; S.O.C. Neurologia, Azienda Ospedaliero Universitaria, "Santa Maria della Misericordia" Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy.
  • Rumiati RI; Area of Neuroscience, SISSA, via Bonomea 265, 34136, Trieste, Italy.
J Neurol ; 266(5): 1113-1119, 2019 May.
Article em En | MEDLINE | ID: mdl-30762102
Although deep brain stimulation of the subthalamic nucleus is an effective surgical treatment for Parkinson's disease, it may expose patients to non-motor side effects such as increased impulsivity and changes in decision-making behavior. Even if several studies have shown that stimulation of the subthalamic nucleus increases the incentive salience of food rewards in both humans and animals, temporal discounting for food rewards has never been investigated in patients who underwent STN-DBS. In this study, we measured inter-temporal choice after STN-DBS, using both primary and secondary rewards. In particular, PD patients who underwent STN-DBS (in ON medication/ON stimulation), PD patients without STN-DBS (in ON medication) and healthy matched controls (C) performed three temporal discounting tasks with food (primary reward), money and discount vouchers (secondary rewards). Participants performed also neuropsychological tests assessing memory and executive functions. Our results show that STN-DBS patients and PD without DBS behave as healthy controls. Even PD patients who after DBS experienced weight gain and/or eating alterations did not show an increased temporal discounting for food rewards. Interestingly, patients taking a higher dosage of dopaminergic medications, fewer years from DBS surgery and, unexpectedly, with better episodic memory were also those who discounted rewards more. In conclusion, this study shows that STN-DBS does not affect temporal discounting of primary and secondary rewards. Furthermore, by revealing interesting correlations between clinical measures and temporal discounting, it also shed light on the clinical outcomes that follow STN-DBS in patients with PD.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Recompensa / Núcleo Subtalâmico / Estimulação Encefálica Profunda / Desvalorização pelo Atraso Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Recompensa / Núcleo Subtalâmico / Estimulação Encefálica Profunda / Desvalorização pelo Atraso Idioma: En Ano de publicação: 2019 Tipo de documento: Article